FDA Inspection
Aventis Pharma Manufacturing Pte. Ltd.Aventis Pharma Manufacturing Pte. Ltd. – FDA Inspection, Jun 13, 2025
Record Details
This FDA Inspection record concerns Aventis Pharma Manufacturing Pte. Ltd., with an inspection on June 13, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 7dbfd7cf-4667-4737-b33f-3f590fac3541
Inspection Facts
- Inspection number
- 1274305
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Aventis Pharma Manufacturing Pte. Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aventis Pharma Manufacturing Pte. Ltd.
- FDA Inspection 1113084 - 2019-11-01
- FDA Inspection 1032305 - 2017-10-13
- FDA Inspection 933845 - 2015-05-22
- FDA Inspection 773423 - 2012-03-09
- FDA Inspection 677605 - 2010-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.